Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | -12,534 | 17,587 | 16,288 | 15,971 | 16,373 |
| Gross Profit | -12,534 | 17,587 | 16,288 | 15,971 | 16,373 |
| Operating Expenses | 46,035 | 40,228 | 35,493 | 31,598 | 31,152 |
| Operating Income | -58,569 | -22,641 | -19,205 | -15,627 | -14,779 |
| Other Income | 80 | 57 | -38 | 73 | 78 |
| Pre-tax Income | -58,489 | -22,584 | -19,243 | -15,554 | -14,701 |
| Net Income Continuous | -58,489 | -22,584 | -19,243 | -15,554 | -14,701 |
| Net Income | $-58,489 | $-22,584 | $-19,243 | $-15,554 | $-14,701 |
| EPS Basic Total Ops | -0.90 | -0.35 | -0.30 | -0.26 | -0.32 |
| EPS Basic Continuous Ops | -0.91 | -0.35 | -0.30 | -0.26 | -0.32 |
| EPS Diluted Total Ops | -0.90 | -0.35 | -0.30 | -0.26 | -0.31 |
| EPS Diluted Continuous Ops | -0.91 | -0.35 | -0.30 | -0.26 | -0.31 |
| EBITDA(a) | $-57,909 | $-21,955 | $-18,388 | $-14,812 | $-14,012 |